Hong Kong Stock Announcement Nuggets | GCL New Energy plans to issue 186.5 million subscription shares and join hands with Pharos to accelerate the integration of Web3 and the new energy industry

Important matters:

GCL New Energy (00451) plans to issue 186.5 million subscription shares and join hands with Pharos to accelerate the integration of Web3 and the new energy industry

Hanson Pharmaceuticals (03692): Amex® (ametinib mesylate tablets) has been issued a drug registration certificate by the State Drug Administration for the fifth indication

Luye Pharmaceutical (02186): The application for marketing in China for a new indication of the Class 1 innovative drug Ruoxinlin® for the treatment of generalized anxiety disorder was accepted

Xianjian Technology (01302): G-iliaTM Pro iliac artery stent system obtained official registration approval from China National Drug Administration

Merry Health International (02327) plans to acquire all shares of Jiangsu Yide for 125 million yuan

Century Entertainment International (00959) Joint Venture signed a Memorandum of Understanding with WPT to jointly develop, operate and commercialize mobile apps

Operating performance:

Express Sales (06288) announced first-quarter results. Profit attributable to shareholders of 147.445 billion yen increased 11.7% year over year

Hejing Taifu Group (01813)'s pre-sales volume in December was 420 million yuan, a year-on-year decrease of 56.7%

Baolong Real Estate (01238)'s total contract sales in 2025 were about 7.272 billion yuan, a year-on-year decrease of 43.13%

CGN Power (01816)'s total feed-in capacity in 2025 is about 232,648 billion kilowatt-hours, up 2.36% year-on-year

Lingbao Gold (03330) Fa Yingxi expects net profit of 2025 to be about 1,503 billion yuan to 1,573 billion yuan, an increase of about 115% to 125% year-on-year